Work

Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma

Year: 2011

Type: article

Study design: Clinical Trial

Source: Journal of Neuro-Oncology

DOI: 10.1007/s11060-011-0717-z

Authors: J. Drappatz, E. Q. Lee, S. Hammond, S. A. Grimm, A. D. Norden, R. Beroukhim, M. Gerard, D. Schiff, A. S. Chi, T. T. Batchelor, L. M. Doherty, A. S. Ciampa, D. C. LaFrankie, S. Ruland, S. M. Snodgrass, J. J. Raizer, P. Y. Wen

Institutions: Center for Neuro-Oncology, Dana-Farber Brigham Cancer Center, Northwestern University, University of Virginia, Massachusetts General Hospital

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Genentech

OpenAlex ID: W2056835378

FWCI: 3.977

Cites: 27

Cited by: 80

Related to: 10